Ovarian cancer Treatment in Uni-asia Cancer hospital

Ovarian cancer treatment at Uni-asia Cancer Hospital in Chengdu, China, focuses on minimally invasive techniques and multidisciplinary care. An online consultation with an oncologist costs around $150, while advanced diagnostics like a PET/CT or a whole-body CT scan cost around $1,300. The facility is a specialized cancer center with 600 beds and uses a multidisciplinary team (MDT) to create personal treatment plans for every patient.

Expertise of Prof. Liao Zhengyin

Prof. Liao Zhengyin leads the oncology team with over 30 years of medical experience. He has performed over 100,000 procedures and previously served as the Director of the Cancer Center at West China Hospital. Prof. Liao Zhengyin is a pioneer in MDT protocols for complex tumors in China and was a senior visiting scholar at Johns Hopkins Hospital in the USA. His work focuses on interventional oncology and tumor pain management.

Diagnostic options

The hospital provides a full range of tests to detect and stage ovarian cancer accurately. These services help determine if the cancer has spread and guide the selection of therapy.

• Online consultation with oncologist. A remote review of medical records and symptoms.
• PET/CT and whole-body CT scans. Imaging to locate tumors and check for metastasis.
• Serum CA-125 and HE4 testing. Blood tests for tumor markers associated with ovarian cancer.
• BRCA and HRD testing. Genetic analysis to identify mutations that respond to specific targeted therapies.
• Pelvic ultrasound. Initial imaging to examine the ovaries and surrounding tissues.

Advanced treatment methods

Uni-asia Cancer Hospital specializes in combining traditional surgery with minimally invasive interventional methods. This approach aims to remove the cancer while reducing physical trauma to the patient.

• Cytoreductive surgery. The primary surgical treatment to remove as much of the tumor as possible.
• Minimally invasive ablation. Image-guided radiofrequency or microwave ablation for recurring tumors.
• Radioactive seed implantation. Using Iodine-125 seeds to treat local recurrences that cannot be removed by surgery.
• Platinum-based chemotherapy. The standard postoperative therapy to destroy remaining cancer cells.
• PARP inhibitor maintenance therapy. Targeted drugs for patients with BRCA mutations to delay disease progression.
• Anti-angiogenic therapy. Medications that block the blood supply to tumors, often used with chemotherapy.

The hospital operates across two campuses in Chengdu and Zigong, offering 80 private rooms for international patients. Its technical platform includes specialized equipment such as the NanoKnife and cryoablation systems. You can request a consultation or a second opinion from the specialists at Uni-asia Cancer Hospital by leaving a request on Bookimed.